The Advisory Committee for Therapeutics (ACT) toolkit provides procedural advice and guidance to replicate the successful TREAT-NMD Advisory Committee for Therapeutics (TACT) model in other rare disease communities. An ACT can provide independent and objective advice to industry and academia, on a real-life therapeutic pathway of drug development programmes. An ACT review can help an applicant to position a candidate compound along a realistic and well-informed pathway to clinical trial and eventual registration.
View this resource Bookmark this resource
Advisory Committee for Therapeutics (ACT) toolkit
Published by UNEW
Clinical DevelopmentTranslational ResearchResearch and Drug DevelopmentTREAT-NMDClinical Trial DesignPreclinical ResearchTemplatesAdvice